Organisation paid for research Program year 2025 Source: CMS Open Payments

AMR Tempe Phoenix

Neither a doctor nor a teaching hospital

Research payments

$14,577

349 payments

Through program year 2025, AMR Tempe Phoenix is reported as receiving $14,577 in research payments, across 349 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$394	14
2024	Research	$822	30
2022	Research	$6,379	168
2021	Research	$6,982	137

Breakdown

Who paid Research payments · program years 2021–2025

Alnylam Pharmaceuticals Inc. $14,577 349 payments

Studies the money was for Research payments · program years 2021–2025

A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) $9,167 241 payments
A Randomized, Double-blind, Placebo-Controlled, Dose-Ranging Multicenter Study to Evaluate the Efficacy and Safety of ALN-AGT01 in Patients With Mild-to-Moderate Hypertension $3,931 94 payments
Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) (KARDIA-2) $1,479 14 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.